Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.
Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

pharma & biotech
China Approves Alzheimer’s Treatment that Targets the Microbiome
China Approves Alzheimer’s Treatment that Targets the Microbiome
Kerry Grens | Nov 5, 2019
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life
Katarina Zimmer | Nov 1, 2019
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
Image of the Day: Upside-Down Landings
Image of the Day: Upside-Down Landings
Emily Makowski | Oct 29, 2019
Blue bottle flies use many different movements and a specific behavior sequence in order to stick a ceiling landing.
Scientists Seek to Kill Genetic Test for Same-Sex Attraction
Scientists Seek to Kill Genetic Test for Same-Sex Attraction
Diana Kwon | Oct 17, 2019
Direct-to-consumer “How Gay Are You?” app sold by GenePlaza has been criticized for being misleading and irresponsible. 
Sanger Institute Accused of Misusing African DNA Samples
Sanger Institute Accused of Misusing African DNA Samples
Kerry Grens | Oct 15, 2019
Whistleblowers allege the institute intended to commercialize a research tool based on the material, a violation of agreements with African scientists who collected the sequences.
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Opinion: Taxpayers Should Cover Portion of Patent Costs
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019
Federal grant support for technology transfer at universities will strengthen the national innovation system.
Genome-Edited Hornless Cows’ Offspring Are Healthy: Study
Genome-Edited Hornless Cows’ Offspring Are Healthy: Study
Kerry Grens | Oct 9, 2019
All six calves inherited the gene for preventing horn growth, but four also got a piece of the plasmid used to introduce the sequence to their dad—complicating regulatory approval.
Brain-Controlled Exoskeleton Enables Paralyzed Patient to Walk
Brain-Controlled Exoskeleton Enables Paralyzed Patient to Walk
Emily Makowski | Oct 4, 2019
The machine cannot be used outside of the lab yet, but the results are promising.